Ferm Translational Pharma Consulting AB

ABIn liquidation

Org 5569252918Research and experimental development on biotechnology · NACE 7211Est. 20130 employees

Overview Financials People & ownership Related companies

Ferm Translational Pharma Consulting AB is a Swedish AB, operating in the Bioteknisk forskning och utveckling sector. Incorporated in 2013, the company has 0 employees and reported revenue of SEK 0 in its latest annual filing.

Revenue 2020

SEK 0

EBITDA margin

—

+50% vs 2019

Equity ratio

97.7%

Financial strength

Net profit 2020

SEK -2K

+50% vs 2019

EBITDA — year on year

SEK millions

Key figures

Annual report 2020

Revenue	SEK 0	—
EBITDA	SEK -2K	+50%
Net profit	SEK -2K	+50%
Total assets	SEK 43K	-4%
Equity	SEK 42K	-5%
Employees	0	—

Contact

Address

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Ferm Translational Pharma Consulting AB?

Ferm Translational Pharma Consulting AB is registered with Bolagsverket / SCB under Org 5569252918.

Who is the CEO of Ferm Translational Pharma Consulting AB?

Mats Olof Torkel Ferm is Chief Executive Officer of Ferm Translational Pharma Consulting AB, in role since 2020.

Who is the chairman of Ferm Translational Pharma Consulting AB?

Inger Maria Zetterström Karlsson chairs the board of Ferm Translational Pharma Consulting AB, in role since 2020.

Ferm Translational Pharma Consulting AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Ferm Translational Pharma Consulting AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Ferm Translational Pharma Consulting AB